Synapse

← COVID

Papers in COVID

Page 14 · newest first

  1. Transmission Pathways and Genomic Epidemiology of Emerging Variants of SARS-CoV-2 in the EnvironmentCOVID · 2022
  2. Latex Allergens in the Ear Straps of Face Coverings and Masks in the UK: Initial FindingsCOVID · 2022
  3. COVID-19 Response in Zimbabwe: The Need for a Paradigm Shift?COVID · 2022
  4. Obstructive Sleep Apnea (OSA) and COVID-19: Mortality Prediction of COVID-19-Infected Patients with OSA Using Machine Learning ApproachesCOVID · 2022
  5. Risk Markers of COVID-19, a Study from South-LebanonCOVID · 2022
  6. The Impact of Maternal SARS-CoV-2 Infection Next to Pre-Immunization with Gam-COVID-Vac (Sputnik V) Vaccine on the 1-Day-Neonate’s Blood Plasma Small Non-Coding RNA Profile: A Pilot StudyCOVID · 2022
  7. Comparable Detection of SARS-CoV-2 in Sputum and Oropharyngeal Swab Samples of Suspected COVID-19 PatientsCOVID · 2022
  8. A Mathematical Epidemiological Model (SEQIJRDS) to Recommend Public Health Interventions Related to COVID-19 in Sri LankaCOVID · 2022
  9. Scalable and Demography-Agnostic Confinement Strategies for COVID-19 Pandemic with Game Theory and Graph AlgorithmsCOVID · 2022
  10. SARS-CoV-2 Detection Limits in Swab and Gargle Samples by Comparing Antigen and RT-qPCR TestingCOVID · 2022
  11. An Overview of SARS-CoV-2 and Technologies for Detection and Ongoing Treatments: A Human Safety InitiativeCOVID · 2022
  12. Tracheomegaly as a Potential Predictor of Severe Tracheal Damage in COVID-19 Patients on Long-Term Mechanical VentilationCOVID · 2022
  13. Dynamics of Variants of Concern (VOC) of SARS-CoV-2 during the Different Waves of COVID-19 in SenegalCOVID · 2022
  14. Public Health Resources, Religion, and Freedom as Predictors of COVID-19 Vaccination Rates: A Global Study of 89 CountriesCOVID · 2022
  15. Evaluation of COVID-19 Reported Statistical Data Using Cooperative Convolutional Neural Network Model (CCNN)COVID · 2022
  16. Examining Risk Perception and Coping Strategies of Senior High School Teachers in Ghana: Does COVID-19-Related Knowledge Matter?COVID · 2022
  17. Impact of Bacterial Infections and Antibiotic Use on Hospitalized COVID-19 Patients: An Emerging Infections Network SurveyCOVID · 2022
  18. KERRA, Mixed Medicinal Plant Extracts, Inhibits SARS-CoV-2 Targets Enzymes and Feline CoronavirusCOVID · 2022
  19. Monoclonal Antibodies as Potential COVID-19 Therapeutic AgentsCOVID · 2022
  20. Imported SARS-CoV-2 Variants of Concern Drove Spread of Infections across Kenya during the Second Year of the PandemicCOVID · 2022
  21. A Reciprocal Cross-Reactivity between Monoclonal Antibodies to SARS-CoV-2 Spike Glycoprotein S1 and Human CXCR2—An Implication of a Viral Mimic of Human CXCR2COVID · 2022
  22. Multifactorial Effects of COVID-19: A Review of Published Autopsy ReportsCOVID · 2022
  23. The Cytokine Storm in COVID-19: The Strongest Link to Morbidity and Mortality in the Current EpidemicCOVID · 2022
  24. Variant Analysis and Strategic Clustering to Sub-Lineage of Double Mutant Strain B.1.617 of SARS-CoV-2COVID · 2022
  25. A Short Overview: Marine Resources as Potential Interventions for the Omicron SARS-CoV-2 VariantCOVID · 2022
  26. Explain Again: Why Are We Vaccinating Young Children against COVID-19?COVID · 2022
  27. Immunogenicity and Reactogenicity of CoronaVac: A Cohort StudyCOVID · 2022
  28. Forensic Analysis of COVID-19 Data from 198 Countries Two Years after the Pandemic OutbreakCOVID · 2022
  29. New Onset Generalized Myasthenia Gravis Evolving Following SARS-CoV-2 InfectionCOVID · 2022
  30. A Randomised, Double-Blind, Placebo-Controlled Trial Evaluating Concentrated Phytochemical-Rich Nutritional Capsule in Addition to a Probiotic Capsule on Clinical Outcomes among Individuals with COVID-19—The UK Phyto-V StudyCOVID · 2022
  31. Nonself Mutations in the Spike Protein Suggest an Increase in the Antigenicity and a Decrease in the Virulence of the Omicron Variant of SARS-CoV-2COVID · 2022
  32. Atorvastatin Reduces the Severity of COVID-19: A Nationwide, Total Population-Based, Case-Control StudyCOVID · 2022
  33. Surface Plasmon Resonance Imaging (SPRi) and Photonic Integrated Circuits (PIC) for COVID-19 Severity MonitoringCOVID · 2022
  34. Early Discharge from a Newborn Nursery in the United States during the COVID-19 PandemicCOVID · 2022
  35. Children Naturally Evading COVID-19—Why Children Differ from AdultsCOVID · 2022
  36. Effect of Community and Socio-Economic Factors on Cardiovascular, Cancer and Cardio-Oncology Patients with COVID-19COVID · 2022
  37. Impact of COVID-19 First Wave on Psychological and Psychosocial Dimensions: A Systematic ReviewCOVID · 2022
  38. Forecast of Omicron Wave Time EvolutionCOVID · 2022
  39. Analyzing the Data of COVID-19 with Quasi-Distribution Fitting Based on Piecewise B-Spline CurvesCOVID · 2022
  40. Exploring the Association of the COVID-19 Pandemic on Employee Sleep Quality at a Healthcare Technology and Services OrganizationCOVID · 2022
  41. A Comprehensive Review of Drug Repurposing Strategies against Known Drug Targets of COVID-19COVID · 2022
  42. Never in Our Imaginations: The Public Human Resources Response to COVID-19 in Northwest FloridaCOVID · 2022
  43. Detecting COVID-19 Status Using Chest X-ray Images and Symptoms Analysis by Own Developed Mathematical Model: A Model Development and Analysis ApproachCOVID · 2022
  44. Gambling and Gaming in the United Kingdom during the COVID-19 LockdownCOVID · 2022
  45. Post-COVID-19 Condition and Health StatusCOVID · 2022
  46. Low Selectivity Indices of Ivermectin and Macrocyclic Lactones on SARS-CoV-2 Replication In VitroCOVID · 2022
  47. Asymptomatic Hypoxemia as a Characteristic Symptom of Coronavirus Disease: A Narrative Review of Its PathophysiologyCOVID · 2022
  48. COVID-19 Pandemic: How Effective Are Preventive Control Measures and Is a Complete Lockdown Justified? A Comparison of Countries and StatesCOVID · 2021
  49. Simultaneous Detection of Seven Human Coronaviruses by Multiplex PCR and MALDI-TOF MSCOVID · 2021
  50. On the Safety of the COVID-19 Convalescent Plasma Treatment: Thrombotic and Thromboembolic ConcernsCOVID · 2021